“…Since the report of fallopian tube carcinoma in the 48-yearold proband of one of the first two families in which pedigree analysis was used by Lynch et al (1974) to establish the familial association of breast and ovarian cancers, as well as the confirming report of fallopian tube cancer by history in a 42year-old member of a breast-ovarian cancer family by Fraumeni et al (1975) just one year later, it has become increasingly evident that primary fallopian tube carcinoma is an integral cancer in the HBOC syndrome and these cancers are associated with germline mutations in BRCA1 and BRCA2 (Agoff et al, 2002;Aziz et al, 2001;Casarsa et al, 2004;Cass et al, 2005;Colgan et al, 2001;Friedman et al, 1995;Hartley et al, 2000;Hé bert-Blouin et al, 2002;Jongsma et al, 2002;Lamb et al, 2006;Leeper et al, 2002;Levine et al, 2003;Maehle et al, 2008;Medeiros et al, 2006;Meeuwissen et al, 2005;Olivier et al, 2004;Paley et al, 2001;Peyton-Jones et al, 2002;Piek et al, 2003a;Powell et al, 2005;Rose et al, 2000;Scheuer et al, 2002;Schubert et al, 1997;Simard et al, 1994;The Breast Cancer Linkage Consortium, 1999;Tong et al, 1999;Tonin et al, 1995;Zweemer et al, 2000). Brose et al (2002) estimated that there is a 120-fold increased lifetime risk for fallopian tube cancer in BRCA1 mutation carriers.…”